LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Novavax Inc

Closed

SectorHealthcare

7.45 6.43

Overview

Share price change

24h

Current

Min

6.98

Max

7.47

Key metrics

By Trading Economics

Income

600M

519M

Sales

578M

667M

P/E

Sector Avg

2.571

51.198

EPS

2.93

Profit margin

77.798

Employees

952

EBITDA

569M

516M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+60.94% upside

Dividends

By Dow Jones

Next Earnings

7 Aug 2025

Market Stats

By TradingEconomics

Market Cap

130M

1.1B

Previous open

1.02

Previous close

7.45

News Sentiment

By Acuity

50%

50%

167 / 380 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Novavax Inc Chart

Past performance is not a reliable indicator of future results.

Related News

2 Apr 2025, 17:06 UTC

Major Market Movers

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31 Mar 2025, 14:19 UTC

Major Market Movers

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 Feb 2025, 18:52 UTC

Major Market Movers

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11 Nov 2024, 14:05 UTC

Major Market Movers

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16 Oct 2024, 12:59 UTC

Major Market Movers

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

19 May 2025, 14:30 UTC

Top News

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

19 May 2025, 13:27 UTC

Top News

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

8 May 2025, 17:55 UTC

Earnings

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

8 May 2025, 15:12 UTC

Earnings

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

28 Apr 2025, 17:04 UTC

Earnings

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

30 Dec 2024, 23:02 UTC

Acquisitions, Mergers, Takeovers

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4 Dec 2024, 07:09 UTC

Acquisitions, Mergers, Takeovers

Novavax: Agreement to Close by Dec 30 >NVAX

4 Dec 2024, 07:08 UTC

Acquisitions, Mergers, Takeovers

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4 Dec 2024, 07:07 UTC

Acquisitions, Mergers, Takeovers

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4 Dec 2024, 07:06 UTC

Acquisitions, Mergers, Takeovers

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4 Dec 2024, 07:06 UTC

Acquisitions, Mergers, Takeovers

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4 Dec 2024, 07:04 UTC

Acquisitions, Mergers, Takeovers

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15 Nov 2024, 13:34 UTC

Top News

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 Nov 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16 Oct 2024, 15:22 UTC

Earnings

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

Peer Comparison

Price change

Novavax Inc Forecast

Price Target

By TipRanks

60.94% upside

12 Months Forecast

Average 11.25 USD  60.94%

High 19 USD

Low 7 USD

Based on 4 Wall Street analysts offering 12 month price targets forNovavax Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

4 ratings

1

Buy

2

Hold

1

Sell

Technical Score

By Trading Central

5.692 / 6.039Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

167 / 380 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.